Moderna Reports Larger-Than-Expected Quarterly Loss
Biotech firm Moderna (MRNA.O) reported a bigger-than-expected quarterly loss, primarily due to charges related to scaling down manufacturing as demand for its COVID-19 vaccine weakens. The company posted a quarterly loss of
